title: Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.
abstract: BACKGROUND
  -There is ample evidence from the solid tumor literature that synoptic reporting improves accuracy and completeness of relevant data. No evidence-based guidelines currently exist for synoptic reporting for bone marrow samples.
  
  
  OBJECTIVE
  -To develop evidence-based recommendations to standardize the basic components of a synoptic report template for bone marrow samples.
  
  
  METHODS
  -The College of American Pathologists Pathology and Laboratory Quality Center convened a panel of experts in hematopathology to develop recommendations. A systematic evidence review was conducted to address 5 key questions. Recommendations were derived from strength of evidence, open comment feedback, and expert panel consensus.
  
  
  RESULTS
  -Nine guideline statements were established to provide pathology laboratories with a framework by which to develop synoptic reporting templates for bone marrow samples. The guideline calls for specific data groups in the synoptic section of the pathology report; provides a list of evidence-based parameters for key, pertinent elements; and addresses ancillary testing.
  
  
  CONCLUSIONS
  -A framework for bone marrow synoptic reporting will improve completeness of the final report in a manner that is clear, succinct, and consistent among institutions.
authors.forename: Cordelia
authors.initials: C
authors.lastname: Sever
authors.forename: Charles L
authors.initials: CL
authors.lastname: Abbott
authors.forename: Monica E
authors.initials: ME
authors.lastname: de Baca
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Khoury
authors.forename: Sherrie L
authors.initials: SL
authors.lastname: Perkins
authors.forename: Kaaren Kemp
authors.initials: KK
authors.lastname: Reichard
authors.forename: Ann
authors.initials: A
authors.lastname: Taylor
authors.forename: Howard R
authors.initials: HR
authors.lastname: Terebelo
authors.forename: Carol
authors.initials: C
authors.lastname: Colasacco
authors.forename: R Bryan
authors.initials: RB
authors.lastname: Rumble
authors.affiliation: From the Department of Hematopathology, Pathology Associates of Albuquerque, Albuquerque, New Mexico (Dr Sever); the Department of Pathology, Berkshire Medical Center, Pittsfield, Massachusetts (Dr Abbott); Medical Laboratory Associates, Seattle, Washington (Dr de Baca); the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Khoury); the Department of Pathology, University of Utah, Salt Lake City (Dr Perkins); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Reichard); Utah Pathology Services, Inc, Salt Lake City (Dr Taylor); the Department of Hematology/Medical Oncology, Newland Medical Associates, Novi, Michigan (Dr Terebelo); the Departments of Governance (Ms Colasacco) and Surveys (Ms Thomas), College of American Pathologists, Northfield, Illinois; and the Quality and Guidelines Department, American Society of Clinical Oncology, Alexandria, Virginia (Mr Rumble).
authors.forename: Nicole E
authors.initials: NE
authors.lastname: Thomas
mesh_terms: D000574:American Medical Association; D001856:Bone Marrow Examination / Q000379:methods; D019337:Hematologic Neoplasms / Q000175:diagnosis*; D006801:Humans; D007753:Laboratories / Q000592:standards*; D000072142:Pathologists; D010338:Pathology, Clinical / Q000379:methods / Q000458:organization & administration / Q000592:standards*; D058028:Research Report / Q000592:standards*; D014481:United States